ABB India wins automation contract from Reliance Life Sciences for biopharmaceutical manufacturing plants

By -


ABB India, a leading global technology and automation company, announced that it has secured a major automation contract from Reliance Life Sciences (RLS), a subsidiary of Reliance Industries, to automate their new biopharmaceutical manufacturing plants in Nashik, Maharashtra.

The contract involves the supply, installation, and commissioning of ABB’s distributed control system (DCS) for the plasma proteins, biopharmaceuticals, oncology pharmaceuticals, and vaccines manufacturing plants at RLS’ 160-acre facility in Nashik. The DCS will enable RLS to monitor, control, and optimize the production processes, ensuring high quality, safety, and efficiency.

G. Balaji, SVP, head of Energy Industries, ABB India said, “This collaboration will reinforce our position in the pharma and life sciences market, where, as a technology provider, we see tremendous potential for growth and innovation. With India rapidly progressing as a prominent biopharmaceutical manufacturing hub, we find ourselves well-poised to ride the wave of the industrial revolution driven by the adoption of automation in these segments, which is pivotal for large-scale production with quality assurance.”

ABB will deliver the DCS on the latest Windows Server 2022 platform, which will ensure extended lifecycle support and best-in-class software management. This helps RLS to avoid any plant shutdowns for software upgrades, ultimately reducing overall costs associated with downtime, software or hardware updates, and related services.

Reliance Life Sciences has the largest number of biosimilars in the market in India and is under development globally. By scaling up its manufacturing facilities, it aims to produce high-quality biosimilars at an affordable cost.

ABB India is one of India’s leading global technology and automation companies. The company operates in four business areas: electrification (EL), motion (MO), process automation (PA), and robotics and discrete automation (RA). The ABB group holds 75% of ABB India through its subsidiary, ABB Asea Brown Boveri Ltd, Zurich.

The company’s net profit zoomed 101% to Rs 296 crore on a 22% rise in revenue to Rs 2,509 crore in Q2 2023 over Q2 2022.

The scrip rose 0.16% to currently trade at Rs 4,283.10 on the BSE.

Comments

Post a Comment

Popular posts from this blog

Deccan Gold Mines Up 150% in a Year, Makes Major Lithium Move in Mozambique

By -
Image
The country's only listed gold exploration and mining company Deccan Gold Mines Limited (DGML) acquired majority stake in 5 lithium blocks in Mozambique, Africa  Deccan Gold Mines Limited (DGML), India's sole listed gold exploration and mining company, has recently made a significant move that has caught the attention of investors worldwide. The company has acquired a majority stake in five lithium blocks in Mozambique, Africa, positioning itself within the globally recognized Alto Ligonha pegmatite belt, known for its abundant reserves of lithium-cesium-tantalum (LCT) pegmatites. {jistoc} $title={Table of Contents} A Strategic Acquisition This acquisition is crucial for the mining of lithium, tantalum, and beryllium. The critical mineral concession block has been procured through Deccan Gold FZCO, a wholly-owned subsidiary of DGML. DGFZCO will hold a majority ownership stake of 51% in DGMOZ, with the potential for this ownership to increase to 70% in the near...
Read more

Small Cap Gem: Sakuma Exports Doubles in 2024, Bonus Share Proposal on July 1st?

By -
Image
Sakuma Exports: A Smallcap Stock with Big Returns in 2024 In the world of stock trading, smallcap stocks often go unnoticed. However, one such stock has been making waves in the Indian stock market - Sakuma Exports Ltd. This company, engaged in the buying, processing, marketing, exporting, and importing of agricultural products, has seen its share price double in the calendar year 2024. {jistoc} $title={Table of Contents} A Stellar Performance As of Thursday, June 20, the Sakuma Exports stock price has recorded a nearly 100% year-to-date gain , hitting the day’s high of ₹37.86 apiece on the NSE. This impressive performance is not a sudden phenomenon but the result of a strong run over the past couple of months. The company's shares have been on a steady upward trajectory, reflecting the positive sentiment among investors. The surge in the stock price is a testament to the company's robust business model and its ability to deliver consistent growth. Bonus Issue ...
Read more

Simple Investing: It's Not Rocket Science (But It Takes More Than Luck)

By -
Image
Successful Investing: Simple, But Not Easy Disclaimer:  This blog post is for informational purposes only and should not be taken as financial advice. Always do your own research and consider seeking advice from a certified financial advisor before making any investment decisions. {jistoc} $title={Table of Contents} The Myth of Easy Wealth The bull market of the 1990s created a myth that the stock market was essentially a high-return savings account. This belief was fueled by the ease of access to financial information and the ability to trade stocks online. However, as many investors discovered when the bubble burst, if something looks too good to be true, it usually is. Investing requires more than just opening an online account and watching financial news. It requires a deep understanding of the market, the ability to analyze and interpret financial data, and the discipline to stick to your investment strategy even when the market is volatile. It also requires...
Read more